The MSCI equity index management team has until its August 2026 quarterly review to determine whether BYD (HK:1211) and Baidu (HK:9888) remain eligible constituents of the MSCI China Index, because the Pentagon's addition of both companies this week to the Section 1260H Chinese Military Company Suspect List activates the mandate review clauses written into the regulated fund structures (UCITS vehicles, pension subaccounts, sovereign wealth overlays) that track MSCI China without separately screening for CMMSL designations. The listing carries no immediate asset freeze, or, more precisely, the mechanism that matters is not the Pentagon's designation but the compliance review it triggers in investment policy statements written before Section 1260H became a routine operational category. Those reviews run on their own calendar, not Beijing's.

Beijing sanctioned Philippine Defense Secretary Gilberto Teodoro in the same week. Both actions compress the same conduit: the SAR's dual-listing infrastructure, which is the specific instrument through which mainland names and foreign capital managers have managed cross-border access since MSCI's 2018 partial A-share inclusion, and which now absorbs both mandate pressures simultaneously. The HKMA's Exchange Fund, which managed approximately HK$4.3 trillion at end-2025, carries mainland index exposure through its Investment Portfolio's equity sleeve, and the Fund's August 2026 quarterly press briefing is the first observable point at which Exchange Fund portfolio managers must state a CMMSL treatment position before the November MSCI semi-annual reconstitution forces the index committee's eligibility determination onto the equity sleeve's books.